Maurizio Scaltriti Selected Research

Maurizio Scaltriti Research Topics

Disease

90	Neoplasms (Cancer) 05/2024 - 07/2003
50	Breast Neoplasms (Breast Cancer) 05/2024 - 04/2007
8	Triple Negative Breast Neoplasms 09/2021 - 11/2012
5	Neoplasm Metastasis (Metastasis) 01/2017 - 07/2003
5	Prostatic Neoplasms (Prostate Cancer) 11/2007 - 01/2004
4	Squamous Cell Carcinoma of Head and Neck 10/2020 - 04/2016
4	Disease Progression 01/2020 - 05/2012
3	Residual Neoplasm 09/2021 - 12/2009
3	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2018
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 12/2015
2	Carcinogenesis 03/2016 - 11/2007
2	Carcinoma (Carcinomatosis) 11/2013 - 01/2004
1	Pneumonia (Pneumonitis) 03/2021
1	Inflammation (Inflammations) 03/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Exanthema (Rash) 01/2020
1	Diarrhea 01/2020
1	Hyperglycemia 01/2020

Drug/Important Bio-Agent (IBA)

25	Phosphotransferases (Kinase)IBA 01/2021 - 07/2006
19	Trastuzumab (Herceptin)FDA Link 05/2023 - 04/2007
17	Estrogen ReceptorsIBA 05/2024 - 11/2010
12	Proteins (Proteins, Gene)FDA Link 05/2023 - 06/2002
11	AlpelisibIBA 05/2024 - 07/2013
11	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2013
10	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 07/2006
9	Lapatinib (GW572016)FDA Link 01/2021 - 04/2007
8	human ERBB2 proteinIBA 01/2021 - 05/2010
8	ErbB Receptors (EGF Receptor)IBA 10/2018 - 09/2006
6	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2024 - 07/2013
6	Hormones (Hormone)IBA 05/2024 - 09/2012
6	Protein Isoforms (Isoforms)IBA 01/2022 - 11/2007
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2007
5	AntibodiesIBA 09/2021 - 07/2006
5	ClusterinIBA 11/2007 - 06/2002
4	Mitogen-Activated Protein KinasesIBA 01/2022 - 04/2007
4	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 02/2015
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 04/2007
4	ipatasertibIBA 01/2021 - 12/2013
4	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 05/2012
4	Fulvestrant (Faslodex)FDA Link 01/2020 - 04/2015
4	larotrectinibIBA 01/2019 - 01/2017
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 06/2013
3	ChromatinIBA 05/2024 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2022 - 06/2002
3	neratinibIBA 01/2021 - 10/2018
3	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2021 - 04/2016
3	Drug CombinationsIBA 01/2021 - 01/2013
3	Ado-Trastuzumab EmtansineIBA 01/2020 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2019 - 10/2004
2	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2020
2	dinaciclibIBA 01/2021 - 11/2016
2	EnzymesIBA 01/2021 - 01/2017
2	Aromatase InhibitorsIBA 10/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 11/2016
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 01/2018
2	capivasertibIBA 01/2020 - 01/2020
2	Cell-Free Nucleic AcidsIBA 11/2019 - 01/2019
2	Cetuximab (Erbitux)FDA Link 01/2019 - 03/2014
2	entrectinibIBA 12/2018 - 11/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2016 - 11/2012
2	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2016 - 03/2014
2	TOR Serine-Threonine KinasesIBA 01/2016 - 03/2015
2	NVP-BKM120IBA 03/2015 - 11/2012
2	ParaffinIBA 02/2014 - 04/2007
2	Everolimus FDA Link 07/2013 - 10/2008
2	AndrogensIBA 11/2007 - 09/2004
2	TeaIBA 09/2007 - 05/2006
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2023
1	APOBEC-1 DeaminaseIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	ribociclibIBA 01/2022
1	selpercatinibIBA 01/2022
1	trametinibIBA 01/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2021
1	Oxygen (Dioxygen)IBA 03/2021
1	canakinumab FDA Link 03/2021
1	A-1331852IBA 01/2021
1	tucatinibIBA 01/2021
1	GlycogenIBA 01/2021
1	UTP-Glucose-1-Phosphate Uridylyltransferase (UDP Glucose Pyrophosphorylase)IBA 01/2021
1	Apoptosis Regulatory ProteinsIBA 01/2021
1	Uridine Diphosphate (UDP)IBA 01/2021
1	S63845IBA 01/2021
1	Uridine Diphosphate Glucose (UDP Glucose)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2020
1	trastuzumab deruxtecanIBA 01/2020
1	AfatinibIBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019

Therapy/Procedure

56	Therapeutics 05/2024 - 09/2006
9	Drug Therapy (Chemotherapy) 01/2021 - 10/2004
4	Immunotherapy 01/2022 - 01/2018
2	Neoadjuvant Therapy 09/2021 - 12/2009
2	Aftercare (After-Treatment) 07/2013 - 05/2012
1	Precision Medicine 04/2021
1	Artificial Respiration (Mechanical Ventilation) 03/2021